Dycom Q2 Earnings Beat Estimates, Revenues Miss, Stock Down

Dycom Industries (DY) reported mixed Q2 FY26 results, with EPS of $3.33 surpassing estimates by 16.4% and increasing 35.4% year-over-year, driven by improved operating leverage. However, contract revenues of $1.378 billion missed consensus by 1.3%, leading to a 4.6% stock decline. Despite the revenue miss, the company reaffirmed its FY26 guidance, underpinned by robust digital infrastructure growth and a 20%+ rise in its 12-month backlog, indicating strong underlying demand.

Analysis

Dycom Industries (DY) reported a mixed second-quarter for fiscal 2026, characterized by a significant earnings beat but a slight revenue shortfall that prompted a negative market reaction. The company's adjusted EPS of $3.33 surpassed consensus estimates by 16.4% and grew 35.4% year-over-year, driven by improved operating leverage. This profitability strength is further evidenced by a 29.8% increase in adjusted EBITDA and a 175 basis point expansion in the adjusted EBITDA margin to 14.9%. However, contract revenues of $1.378 billion missed estimates by 1.3%, triggering a 4.6% decline in the stock price. Despite this top-line miss, the underlying demand drivers remain robust; total revenue still grew 14.5% year-over-year, with acquisitions contributing $139.8 million. More critically, the company's 12-month backlog increased by over 20% to $4.604 billion, and management reaffirmed its full-year revenue growth guidance of 12.5% to 15.4%, indicating confidence in future execution. While the balance sheet shows an increase in long-term debt to $1.01 billion and a lower cash position, the company is actively returning capital through share repurchases, signaling management's belief in the stock's value.

Key Decisions for Investors

• The 4.6% stock decline on a marginal revenue miss could be viewed as a buying opportunity, given the company's strong fundamentals, including a 35.4% EPS beat and significant margin expansion.
• Investors should monitor the company's ability to convert its robust backlog, which has a 12-month component up over 20%, into sustained organic revenue growth to validate the reaffirmed full-year guidance.
• It is prudent to scrutinize the balance sheet in coming quarters, specifically the rising long-term debt and reduced cash levels, as a key risk factor to weigh against the positive operational results and strong demand outlook.